Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results

te hereof. This press release and prior releases are available at The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

Lauren Fischer
Director – Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: Keryx Biopharmaceuticals, Inc.Selected Consolidated Financial Data(In Thousands, Except Share and Per Share Amounts)Statements of Operations Information (Unaudited):Three Months Ended
June 30,Six Months Ended
June 30,2011201020112010REVENUE:License revenue




--OPERATING EXPENSES:Research and development:Non-cash compensation




676Other research and development




5,683Total research and development




6,359General and administrative:Non-cash compensation




668Other general and administrative




2,254Total general and administrative







9,281OPERATING LOSS(3,218)



(9,281)OTHER INCOME:Interest and other income, net




112NET LOSS$  (3,096)

$  (5,154)


Basic and diluted net loss per common share








57,658,247Balance Sheet Information:June 30,

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
2. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
3. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
4. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
7. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
8. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
10. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
11. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
(Date:6/2/2015)... , June 2, 2015 Today ... joins over 150 major food companies, retailers, and ... House Forum on Antibiotic Stewardship. CSTE is committed ... antibiotic-resistant bacteria, detect resistant strains, preserve the efficacy ... of resistant infections. CSTE continues to ...
(Date:6/2/2015)... , June 2, 2015  ErgoNurse, the leader in bedside ... healthcare products in the United States , ... home, long-term care and skilled nursing markets. ... Thousands ... to fully take advantage of the ErgoNurse products to stop ...
(Date:6/2/2015)... CAMBRIDGE, Mass. , June 2, 2015 /PRNewswire/ ... has expanded its offerings with the addition of ... ARISg™, a world leader in safety data collection ... safety and regulatory affairs professionals, and expert physicians, ... industry, provide clinical interpretation and monitoring of safety ...
Breaking Medicine Technology:ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2PROMETRIKA Announces the Availability of Pharmacovigilance Services 2
(Date:6/2/2015)... 2015 Highly qualified dental care specialists inside ... drive prolific change in the dental tourism industry in Europe. ... Clinic offers a full range of superior dental services ... dental tourism. , Partnered with a top medical tourism ... advancing dentistry and has earned a reputation as an influential ...
(Date:6/2/2015)... Orlando, FL (PRWEB) June 02, 2015 ... can enjoy quality care in a more convenient location ... Publix in Partin Village Plaza, 2310 E. Irlo Bronson ... location is located less than a mile away from ... with warm décor, more spacious patient areas with digital ...
(Date:6/2/2015)... June 02, 2015 The Down Syndrome ... Potter from the hit show Glee as the keynote ... Walk in Pleasant Prairie, WI. The event aims to ... in Racine, Kenosha, and Walworth counties. ... join us for this important event," says Dawn Nuoffer, ...
(Date:6/2/2015)... 2015 The 3TVPhoenix contest, conducted in partnership ... station’s 6:00 a.m. Good Morning Arizona program for a code ... Facebook page. , Lisa Allen of Scottsdale was ... plans to apply the monthly $1,000 prize to her mortgage ... mom, expressed her surprise and gratitude at winning, indicating that ...
(Date:6/2/2015)... Los Angeles (PRWEB) June 02, 2015 ... a letter of intent to partner and expand urgent ... is subject to approval by the University of California ... The planned transaction will allow UCLA Health to purchase ... centers in Beverly Hills, Calabasas, Newbury Park and Northridge ...
Breaking Medicine News(10 mins):Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2
... Service Employees International Union taking immediate legal ... by California Nurses,Association, WASHINGTON, April 17 ... announced plans to file a motion to,dismiss ... the California,Nurses Association against SEIU President Andy ...
... of America,(PHA) today strongly denounced efforts by opponents ... farm bill in their continuing effort,to close all ... the latest effort by opponents of hospitals that ... and non-physician,corporations and has already drawn strong criticism ...
... the cancer may have an Achilles, heel, report suggests , , ... has forced metastatic melanoma into remission for the first time, ... The case involves a 79-year-old woman with melanoma tumors in ... abnormality in a gene called KIT, so the patient was ...
... MONICA, Calif., April 17 Consumer,Watchdog today praised ... insurance coverage of patients left uninsured, uninsurable,and often ... when their,health insurance policies were illegally cancelled after ... that reinstatements must be,complete and retroactive, with no ...
... 17 The American,Chemistry Council (ACC) today sent ... FDA to update its review of the safety ... extensive body of scientific study regarding bisphenol A ... reports have,raised concerns about the safety and use ...
... money for crucial research, advocacy and ... ... announced its first-ever national fundraising and awareness,campaign -- the Hemophilia Walk, presented ... partner with local,chapters in five cities across the U.S. to raise much ...
Cached Medicine News:Health News:SEIU to File Motion to Dismiss CNA Restraining Order 2Health News:Physician Hospitals of America Denounces 'Farm Bill' Plan to Sell Out Seniors and Physicians to Pay for Agribusiness Subsidies 2Health News:Gleevec Pushes Advanced Melanoma Into Remission 2Health News:Consumer Watchdog Praises CA HMO Regulator's Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered 2Health News:ACC Calls on FDA to Update Review of Bisphenol A 2Health News:ACC Calls on FDA to Update Review of Bisphenol A 3Health News:National Hemophilia Foundation Asks America to Make a Difference With National Fundraising Initiative 2
Helical Stone Basket...
Nitinol Tipless Stone Basket...
A breakaway microwell EIA for the detection of toxins produced by Enterohemorrhagic E. coli...
For presumptive identification of E. coli serogroup O157:H7 cultured on laboratory media....
Medicine Products: